Seroprevalence and Association of Toxoplasma gondii with Bone Health in a Cohort of Osteopenia and Osteoporosis Patients
-
Published:2024-06-24
Issue:7
Volume:12
Page:1400
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Karunakaran Indulekha1, Surendar Jayagopi2, Ransmann Pia2ORCID, Brühl Marius2ORCID, Kowalski Silvia2, Frische Victoria2, Hmida Jamil2ORCID, Nachtsheim Sabine1, Hoerauf Achim13ORCID, Wirtz Dieter C.2ORCID, Hübner Marc P.13ORCID, Strauss Andreas C.2ORCID, Schildberg Frank A.2ORCID
Affiliation:
1. Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, 53127 Bonn, Germany 2. Department of Orthopedics and Trauma Surgery, University Hospital Bonn, 53127 Bonn, Germany 3. German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 53127 Bonn, Germany
Abstract
Considering the fact that Toxoplasma is a common parasite of humans and Toxoplasma bradyzoites can reside in skeletal muscle, T. gondii-mediated immune responses may modulate the progression and pathophysiology of another musculoskeletal disorder, osteoporosis. In the current study, we investigated the association of bone health and Toxoplasma gondii infection status. A total of 138 patients living in Germany with either osteopenia or osteoporosis were included in the study, and they were categorized into two groups, T. gondii uninfected (n = 74) and infected (n = 64), based on the presence of T. gondii-specific IgG antibodies. The demographic and clinical details of the study subjects were collected from the medical records. Logistic regression analysis was performed to delineate the association of bone health parameters with the infection status. The prevalence of toxoplasmosis was 46.4% in the study participants. The infected individuals with osteopenia and osteoporosis showed higher levels of mean spine and femoral T score, Z score, and bone mineral density (BMD), indicating improved bone health compared to the uninfected group. Logistic regression analysis showed that subjects with T. gondii infection displayed increased odds of having a higher mean femur T score, femur BMD, and femur Z score even after adjusting for age, creatinine, and urea levels. However, when the duration of drug intake for osteoporosis was taken into account, the association lost statistical significance. In summary, in this study, an improvement in osteopenia and osteoporosis was observed in Toxoplasma-infected patients, which may be partly due to the longer duration of drug intake for osteoporosis in the infected patient group.
Funder
Deutsche Forschungsgemeinschaft German Center for Infection Research John Templeton Foundation DFG Principal investigator grant University Hospital Bonn BONFOR
Reference26 articles.
1. Guder, C., Gravius, S., Burger, C., Wirtz, D.C., and Schildberg, F.A. (2020). Osteoimmunology: A Current Update of the Interplay between Bone and the Immune System. Front. Immunol., 11. 2. Kanis, J. (2007). Assessment of Osteoporosis at the Primary Health-Care Level, WHO Scientific Group. Technical Report. 3. Bone density and fracture risk in men;Melton;J. Bone Miner. Res.,1998 4. Perspective. How many women have osteoporosis?;Melton;J. Bone Miner. Res.,1992 5. Epidemiology, treatment and costs of osteoporosis in Germany—The BoneEVA Study;Gothe;Osteoporos. Int.,2007
|
|